Adapting a natural language processing tool to facilitate clinical trial curation for personalized cancer therapy

AMIA Jt Summits Transl Sci Proc. 2014 Apr 7:2014:126-31. eCollection 2014.

Abstract

The design of personalized cancer therapy based upon patients' molecular profile requires an enormous amount of effort to review, analyze and integrate molecular, pharmacological, clinical and patient-specific information. The vast size, rapid expansion and non-standardized formats of the relevant information sources make it difficult for oncologists to gather pertinent information that can support routine personalized treatment. In this paper, we introduce informatics tools that assist the retrieval and curation of cancer-related clinical trials involving targeted therapies. Particularly, we adapted and extended an existing natural language processing tool, and explored its applicability in facilitating our annotation efforts. The system was evaluated using a gold standard of 539 curated clinical trials, demonstrating promising performance and good generalizability (81% accuracy in predicting genotype-selected trials and an average recall of 0.85 in predicting specific selection criteria).